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Abstract 
Background: Interleukin (IL)-27 is a heterodimeric cytokine belonging to IL-12 and IL-23 families, secreted  
by antigen presenting cells(APCs). The IL-27 is composed of 2 subunits: Epstein-Barr virus induced gene 3 
(EBI3) and p28. IL-27 is an anti-inflammatory cytokine which has an inhibitory effect on Th17 population and 
suppress the IL-17 expression. It is suggested that IL-27 could be a potent drug candidate for treating auto 
immune diseases. 
Materials and Methods: The EBI3 and p28 subunits of human interleukin 27 were constructed into plasmid 
vectors; they sub-cloned into pETDuet-1 expression vector in restriction sites of BamHI, SacI and NotI. 
Subsequently the induction was carried out by 1mM IPTG and the recombinant proteins were confirmed by 
SDS-PAGE and Western Blot analysis using anti His-tag antibody. 
Results: The EBI3 and p28 subunits of human interleukin 27were cloned into plasmid vectors. The 28 and 
25kDa protein bands were observed on SDS-PAGE and finally confirmed by Western blot technique. 
Conclusion: In this research p28 and EBI3 proteins were produced successfully. 
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Introduction 
IL-27 is a heterodimer protein containing Epstein-
Barr-induced gene 3 (EB13) protein and also is a 
member of interleukin 12 and 23 families. This 
cytokine is a very important factor in association 
with the differentiation of Th1 lymphocytes and has a 
close relation with enhancers of cellular immune 
responses and also inhibitors of Th2 humoral 
immunity
1
 and may affect other cells such as Th17 
and B lymphocytesor NK cells
2
. In comparison with 
other cytokines, the subunits of IL-12 and IL-27 
families are non-covalently bonded; therefore, the two 
subunits are produced by different cells and then they 
bind together in the extra cellular areas
3
.IL-27 is an 
anti-tumor cytokine and inhibits angiogenesis.There 
has been seen a relation between IL-27 and induction 
of MHC class I in TBJ cells (neurocytic tumor). 
Furthermore there are some researches that have 
showed a decrease in the number of CD8+ 
lymphocytes that has led to IL-27 anti-tumoral effect 
in colon cancer cells and glial cells
4
. 
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Low expression of MHC I and reduced function of 
IL-21 receptors have substantially decreased anti-
tumoral effect of IL-27 in B10F16 melanoma. 
Transferring of IL-27 into tumoral cells has resulted 
in tumoral cells with lower density and slower 
growth rate compared to the primary tumors
5
. IL-27 
has a role in decreasing metastasis possibility with 
about 98 percent beside its inhibitory capacity in 
tumor angiogenesis
1
. 
IL-27 is a choice to treat autoimmune diseases. Since 
this is an anti-inflammatory agent and inhibits the 
increase of IL-17, it can be used as a therapeutic 
potential to treat autoimmune diseases such as 
Multiple Sclerosis, Rheumatoid Arthritisand 
Psoriasis Vulgaris. It can also inhibit and reduce the 
severity of EAE
2
 in the mice infected with MS 
6,7
. 
Animal based studies on CIA Arthritis model showed 
that IL-27 inhibits the expression of transcription 
essential factors
8
.  
IL-27 is an anti-viral agent and reduces replication of 
HIV-1 in CD4+ T cells, peripheral blood 
mononuclear cells (PBMCS) and macrophages
9
. IL-
27 induces the expression of interferon type 1 and 
IFN regulatory genes
10
. Based on mentioned 
researches, recombinant IL-27 is appropriate for 
medical care and treatment of viruses especially 
AIDS
11
. 
Interleukin 27 like other Cytokines has the main role 
in inducing and limiting of inflammations
12
. It has 
the potential to empower early phase of immune 
response, inhibits Th2 and plays a role in the 
differentiation of Th17. The main 
immunosuppressive role of this interleukin, which is 
associated with inhibition of IL-2 and opposition to 
IL-6, is to suppress the progression of Th17 and to 
induce the production of IL-10, and to activate the 
expression of suppressors-of-cytokine-signaling 
(SOCS)
13,14
. 
The role of IL-27, especially in cancers, Multiple 
Sclerosis, and Rheumatoid Arthritisfurther the 
activity of IL-27 may facilitate toprove IL-27 
recombinant form as a drug for these diseases. 
Methods 
EP repairing P28 and EBI3 Segments 
Nucleotide sequence of the genes encoding P28                         
(NM_145659.3), and EBI3 (NM_005755.2) subunits 
were taken from NCBI. These sequences were 
changed based on E. coli (host) amino acid codon 
usage and synthesized by Gene ray Biotechnology. 
The primers were designed (Table 1) and 
amplification of EBI3 (690bp) and p28 (759bp) genes 
were carried out and final fragments contain 
SacI/NotIandSacI/BamHI restriction sites in the two 
ends respectively. 
PCR was conducted using the following ingredients 
1µg plasmid, 0.2mM dNTPs, 10 mM MgCl2, 1× PCR 
buffer, 2 pmol of each reverse and forward primer, 1U 
Taq DNA polymerase (Cinagen, Iran) and water was 
added up to the final volume of  30µL.  
The following PCR program was used 
Denaturation at 94°C for 30 seconds, annealing at 
68°C for 30 seconds, and extension at 72°C for 40 
seconds; cycles were repeated for 30 times. At the 
beginning and end of the reaction, the adjusted 
temperatures (94 and 72°C) were fixed for 5 minutes. 
amplicons were detected by electrophoresis on 1.5% 
agarose gel and results were observed under UV light 
by SYBR Green.  
Gene Segments Cloning into Expression Vector 
pET Duet-1 
The PCR products, digested by the restriction 
enzymes. Final products were electrophoresed on 
agarose gel, and were recovered using a specific kit 
(Bioneer, Korea). Expression plasmid pET Duet-1 was 
digested by restriction enzymes on both sided of the 
inserts. The ligation of inserts into vectors was carried 
out by using T4 DNA Ligase (Fermentas, 
Lithuania)15. 
The cloning of these two genes were confirmed by 
universal PCR and sequencing of PCR product. 
 
Table 1: EBI3 and P28 specific primers. 
 
EBI3  
primers 
F: 
5’AGATCTCAGAGCTCATGACCCCGCAGCTTCTC 
3’ 
R: 
5’CGTGGCCGCGGCCGCCTACTTGCCCAGGCTC3’ 
p28 
primers 
 
F: 
5’AGATCTCAGAGCTCATGACCCCGCAGCTTCTC 
3’ 
R: 5’ACCGGTGGAGCTCATCAGGGCTGGGGGCTC 
3’ 
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Expression of Recombinant Proteins EBI3 and 
p28 
Recombinant pET Duet-1 plasmids containing EBI3 
and p28 were transformed into E. coli BL21 on LB 
agar media with ampicillin. Cells with recombinant 
plasmids were cultured in LB broth at 37°C and 
incubate overnight in 200 rpm. 1mM IPTG has been 
used for induction of it. After different 
hourssediment samples were collected. Proteins of 
each sample were prepared for electrophoresis on 
15% SDS-PAGE gel, the non-recombinant bacteria 
were used as negative control. To approve the 
expression of proteins in the bacteria, Western Blot 
test was conducted using specific his-tag conjugated 
antibody. 
Results 
Amplification of EBI3 and p28 Fragments 
PCR was performed by the specific primers for both 
EBI3 and P28 genes 
(Figure 1a and b). 
Cloning confirmation of genes 
After sub-cloning of EBI3 and p28 genes, PCR was 
performed by pET-Duet1 universal primers. The 
PCR products were electrophoresed on agarose gel 
1.5% (Figure 2). 
EBI3 and P28 Expression and Approved by 
Western-Blotting 
The expressions of proteins were induced using 1mM 
IPTG. The samples were electrophoresed on 12% SDS-
PAGE gel and transferred to nitrocellulose membrane. 
Western-blot analysis by alkaline phosphatase 
conjugated His-Tag antibody revealed the protein bands 
(Figure 3). 
Discussion 
Studies conducted on IL-27 showed that it can affect 
the growth and density of tumors and also can inhibit 
angiogenesis
5
 of early tumors and metastasis
1
. So 
scientists believe that IL-27 can help the treatment of 
tumors
8
.Since IL-27 is an anti-inflammatory agent 
and inhibits IL-17, it can be introduced as a 
therapeutic agent against autoimmune diseases
7
. It 
can also be considered as a strong obstacle for HIV-1 
replication
9
. Based on previous reports recombinant 
IL-27 can be used in the treatment of viral infections, 
especially AIDS
11
. Considering the extensive 
biological properties of this valuable cytokine, and the 
importance of this factor in the treatment and its 
pharmaceutical role, and considering the results of 
other researches, the authors of the current study 
decided to produce two subunits of IL-27 in vitro 
using one of the recombinant protein production 
techniques
13
. At the present study, we used pre-
synthesized genes for the experiment. 
Pflanz et al. evaluate the early identification of IL-27
3
. 
Hu et al. also performed pig P28 subunits cloning
16
. 
 
 
Figure 1. P28 (a) and EBI3 (b) PCR Products against 100bp 
DNA Ladder 
 
 
 
Figure 2. The Confirmation of EBI3 and P28 cloning by 
Universal PCR 
 
 
 
Figure 3. Western Blot analysis of EBI3 and P28 
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The applied method is common for cloning and has 
been used in different studies
17
. Lack of disulfide 
bond in IL-27 allows these two subunits to be 
produced by different cells and be conjugated 
together in the extracellular space. Evaluation of pure 
IL-27 p28 or EBI3 biological activity in vitro showed 
that any one of them individually is active and does 
not need another one
13
. The aforementioned results 
confirm the separate expression of EBI3 and P28 in 
different vectors of the current study, since 
evaluating the performance and role of these subunits 
by separate proteins leads more useful results. To 
express IL-27 subunits in the E. coli expression 
system, the pET Duet-1 expression vector was used. 
There are different plasmid vectors to express genes 
in E. coli, including pGEX, pQE30 and pET vectors. 
Phage T7 promoter was used in pET system, it is a 
specific strong promoter and RNA polymerase of E. 
coli cannot recognize it, while promoters of pGEX 
and pQE are transcribed by E. coli RNA 
polymerase
18
. Expression of IL-27 subunits by pET 
Duet-1 vector resulted in the production of IL-27 
subunits which any one of them is observed as a 
separate band in the competent bacteria. The results 
of the current study showed that this system is a 
suitable host to produce the recombinant IL-27 and 
using bacterial system (BL21DE3) is a quick and less 
costly method. The current study is the first report for 
human IL-27 gene cloning and expression in Iran. 
Conclusion 
In this research p28 and EBI3 recombinant proteins 
were produced in prokaryotic system successfully. 
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